Quote | Synairgen PLC Ord (OTCMKTS:SYGGF)
Last: | $0.06 |
---|---|
Change Percent: | 26.23% |
Open: | $0.045 |
Close: | $0.06 |
High: | $0.06 |
Low: | $0.045 |
Volume: | 50,002 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Synairgen PLC Ord (OTCMKTS:SYGGF)
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden speaks to Thomas Warner from Proactive London about the company's ongoing efforts to develop what he describes as a "drug to help patients handle respiratory viruses." He explains that work on the drug lon...
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden talks to Proactive following the release of full year results for calendar year 2022 - a year he says was "quite challenging at times." Marsden discusses the UK-based respiratory company's clinical development...
Message Board Posts | Synairgen PLC Ord (OTCMKTS:SYGGF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Synairgen PLC Ord Company Name:
SYGGF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden speaks to Thomas Warner from Proactive London about the company's ongoing efforts to develop what he describes as a "drug to help patients handle respiratory viruses." He explains that work on the drug lon...
(NewsDirect) Synairgen PLC (AIM:SNG, OTC:SYGGF) chief executive Richard Marsden talks to Proactive following the release of full year results for calendar year 2022 - a year he says was "quite challenging at times." Marsden discusses the UK-based respiratory company's clinical development...